Finance

Lists
NSB:ASX
Neuroscientific Biopharmaceuticals Ltd
0,063 A$
+1,61%
(+0,0010) 1D
7 հոկ, 11:34:30 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NSB...
Open
0,06 A$
High
0,06 A$
Low
0,06 A$
Mkt. cap
24,96 մլն
Avg. vol.
124,73 հզր
Volume
26,00
52-wk high
0,18 A$
52-wk low
0,06 A$
EPS
-0,01 A$
Shares outstanding
389,72 մլն
Open
0,06 A$
High
0,06 A$
Low
0,06 A$
Mkt. cap
24,96 մլն
Avg. vol.
124,73 հզր
Volume
26,00
52-wk high
0,18 A$
52-wk low
0,06 A$
EPS
-0,01 A$
Shares outstanding
389,72 մլն
News stories
From web sources and news partners
About Neuroscientific Biopharmaceuticals Ltd
CEO-
Employees-
Founded2002
Headquarters-
Sector-
Last report
28 հլս, 2026 թ.
Fiscal period
Q4 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
42,38 հզր / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
158,95 հզր
158,95 հզր
42,38 հզր
42,38 հզր
Cost of goods sold
23,53 հզր
23,53 հզր
48,66 հզր
48,66 հզր
Cost of revenue
23,53 հզր
23,53 հզր
48,66 հզր
48,66 հզր
Research and development expenses
225,61 հզր
225,61 հզր
316,20 հզր
316,20 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
409,06 հզր
409,06 հզր
628,30 հզր
628,30 հզր
Operating expense
1,04 մլն
1,04 մլն
1,44 մլն
1,44 մլն
Total operating expenses
1,07 մլն
1,07 մլն
1,49 մլն
1,49 մլն
Operating income
-908,64 հզր
-908,64 հզր
-1,44 մլն
-1,44 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-849,71 հզր
-849,71 հզր
-1,50 մլն
-1,50 մլն
EBT excluding unusual items
-849,71 հզր
-849,71 հզր
-1,39 մլն
-1,39 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-849,71 հզր
-849,71 հզր
-1,50 մլն
-1,50 մլն
Net profit margin
-534,56%
-534,56%
-3 532,28%
-3 532,28%
Earnings per share
-
-
-
-
Interest and investment income
59,20 հզր
59,20 հզր
54,17 հզր
54,17 հզր
Interest expense
-263,00
-263,00
-1,57 հզր
-1,57 հզր
Net interest expenses
58,94 հզր
58,94 հզր
52,60 հզր
52,60 հզր
Depreciation and amortization charges
383,00
383,00
6,24 հզր
6,24 հզր
EBITDA
-597,26 հզր
-597,26 հզր
-1,06 մլն
-1,06 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps